Strafford will be offering a webinar entitled "Paragraph IV Litigation and IPRs — Interplay Between Paragraph IV Litigation and IPRs, Multiple Generic Challengers, Key Issues in IPRs" on April 5, 2018 from 1:00 to 2:30 pm (EDT). Erin M. Dunston, Matthew L. Fedowitz, and Mythili Markowski of Buchanan Ingersoll & Rooney will discuss strategies for using IPRs in relation to Hatch-Waxman litigation, how pharmaceutical patents fare in post-grant challenges in comparison to all patents, and what the crucial issues are in post-grant challenges involving pharmaceutical patents. The webinar will review the following issues: • Where do multiple generic challengers fit…Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.